GSK-2018682
Pou rechèch syantifik sèlman, pa pou pasyan yo.
Pwodwi detay
Tags pwodwi
Gwosè pake | Disponibilite | Pri (USD) |
Non chimik:
4-(4-(5-(5-chloro-6-isopropoxypyridin-3-yl)-1,2,4-oxadiazol-3-yl)-1H-indol-1-yl)butanoic asid
Kòd SMILES:
O=C(O)CCCN1C=CC2=C1C=CC=C2C3=NOC(C4=CC(Cl)=C(OC(C)C)N=C4)=N3
Kòd InChi:
InChI=1S/C22H21ClN4O4/c1-13(2)30-22-17(23)11-14(12-24-22)21-25-20(26-31-21)16-5 -3-6-18-15(16)8-10-27(18)9-4-7-19(28)29/h3,5-6,8,10-13H,4,7,9H2,1 -2H3,(H,28,29)
InChi kle:
NFIGDBFIDKDNIG-UHFFFAOYSA-N
Mot:
1034688-30-6;CAS:1034688-30-6;CAS:1034688-30-6;GSK-2018682;GSK 2018682;GSK2018682; 2018682
Solibilite:Soluble nan DMSO
Depo:0 - 4 C pou kout tèm (jou a semèn), oswa -20 C pou long tèm (mwa).
Deskripsyon:
GSK2018682 se yon agonist pou reseptè S1P1 ak S1P5.
Sib: Agonist pou reseptè S1P1 ak S1P5